We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

By MedImaging International staff writers
Posted on 22 Mar 2024
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without prompt treatment. Considering the importance of early detection, researchers have now developed an artificial intelligence (AI) system that automatically and reliably detects cardiac amyloidosis during scintigraphy imaging.

The new AI system was developed and validated by an international research team led by Medical University Vienna (Vienna, Austria), utilizing data sets from 16,000 patients who underwent a scintigraphy imaging examination across Europe and Asia between 2010 and 2020. Scintigraphy, a nuclear medicine procedure, is instrumental in identifying various diseases, such as cancer, thyroid, kidney, and heart disease. The AI tool significantly enhances the speed of diagnosing cardiac amyloidosis by automatically detecting the condition during the scintigraphy imaging process.

The AI system’s accuracy was also rigorously tested by comparing it with the diagnostic capabilities of medical professionals. The results showed that the AI tool could identify cardiac amyloidosis with a reliability that matches or even surpasses that of medical experts. Further analysis by the research team delved into the relationship between AI-detected diagnoses of cardiac amyloidosis and subsequent health outcomes. The findings revealed that patients diagnosed with the condition by the AI tool faced double the risk of mortality and a more than seventeen-fold increase in the risk of developing heart failure compared to those not diagnosed with amyloidosis by the AI system.

"In the future, our findings and the technology we have developed could enable screening for cardiac amyloidosis among all scintigraphy patients, with the AI system evaluating the image data in parallel with doctors," said Clemens Spielvogel from MedUni Vienna's Department of Biomedical Imaging and Image-guided Therapy.

Related Links:
Medical University Vienna

Multi-Use Ultrasound Table
Clinton
Biopsy Software
Affirm® Contrast
Digital Radiography System (Ceiling Free)
Digix CF Series
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+

Channels

General/Advanced Imaging

view channel
Image: A multinational study reports that AI can quickly generate clinically acceptable radiotherapy plans across care settings (Photo courtesy of Adobe Stock)

AI Tool Automates Radiotherapy Planning for Cervical and Prostate Cancer

Cervical cancer causes most of its global mortality in low- and middle-income countries, where radiotherapy capacity and specialist staff are limited. Treatment planning is labor-intensive and can delay... Read more

Imaging IT

view channel
Image: Researchers develop a vision-language model trained on large-scale data to generate clinically relevant findings from chest computed tomography images through visual question answering (Ms. Maiko Nagao from Meijo University, Japan)

Interactive AI Tool Supports Explainable Lung Nodule Assessment

Lung cancer is a leading cause of cancer mortality, and timely characterization of pulmonary nodules on chest computed tomography (CT) is essential for directing care. Interpreting nodule morphology demands... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.